Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.11
Delayed Data
As of Jul 31
 +0.06 / +0.99%
Today’s Change
3.33
Today|||52-Week Range
6.85
+46.52%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$368.9M

Company Description

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories to provide genetic and molecular testing services. The company offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry and Molecular testing. It offers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Contact Information

NeoGenomics, Inc.
12701 Commonwealth Drive
Fort Myers Florida 33913
P:(239) 768-0600
Investor Relations:
(239) 325-2001

Employees

Shareholders

Other institutional39.45%
Individual stakeholders21.81%
Mutual fund holders15.96%

Top Executives

Douglas M. VanOortExecutive Chairman & Chief Executive Officer
Robert J. ShovlinChief Operating Officer
George A. CardozaChief Financial Officer
Maher AlbitarChief Medical Officer
Steven A. RossChief Information Officer